In 2041 SARS-CoV-2-negative household contacts of Covid-19 patients, 5 days of ensitrelvir started within 72 hours cut symptomatic Covid-19 by day 10 vs placebo (2.9% vs 9.0%; RR 0.33); adverse events were similar (15.1% vs 15.5%).
RCTn = 2,041
Hayden et al. Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts